R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

pharmaphorum podcast Episode 191a, Ben Sidders

Ben Sidders on integrating causality in AI for R&D success

Ben Sidders, chief scientific officer at Biorelate, discusses leveraging advanced data science methods to transform the focus and impact of R&D.

R&D

Three scientists discuss a grant application

What to do when your grant application fails

All hope should not be lost and an unsuccessful application doesn’t always mark the end of the road.

R&D

Post-hype, pre-value: The real AI-pharma shift starts now

The first era of AI in pharma was built on potential. This next era will be built on proof, reinforcing even greater potential.

R&D

When is the superbug message going to bite?

As existing antibiotics become less effective, we edge closer to a future where routine infections & minor injuries could once again become high risk.

R&D

Doctor looking at the data in healthcare setting

From data to impact: How real-world evidence will transform ...

Real-world evidence (RWE) has moved from the periphery to the centre of how healthcare decisions are made.

R&D

pharmaphorum podcast Episode 188a - Novo Nordisk and Veeva

Maximising value by uniting the digital backbone: On a new N...

Novo Nordisk and Veeva have entered into a new partnership for clinical development.